European Journal of Neurology · 2013 · 68 citations · 28 references
MedicinePharmacologyPharmacotherapyCerebrovascular SurgeryClinical PharmacologyNeurologic PharmacotherapyCerebral EdemaCerebrovascular DiseaseHemorrhage ControlIntracerebral HemorrhageStroke PharmacotherapySubarachnoid Hemorrhage ManagementAcute Hemorrhagic Stroke ManagementControl Group DesignHematoma Volume ReductionHemorrhage ReductionHemorrhage Severity AssessmentIntracranial Hemorrhage PharmacotherapyMatched Control GroupPerihematomal Edema
BACKGROUND AND PURPOSE: We investigated the effect of celecoxib, a selective inhibitor of cyclo-oxygenase 2, in patients with intracerebral hemorrhage (ICH). METHODS: We conducted a multicenter, randomized, controlled, and open with blinded end-point trial of 44 Korean patients 18 years or older with ICH within 24 h of onset. The intervention group (n = 20) received celecoxib (400 mg twice a day) for 14 days. The control group (n = 24) received the standard medical treatment for ICH. The primary end-point was the number of patients with a change in the volume of perihematomal edema (PHE) from the 1st to the 7th ± 1 day (cut-off value, 20%). RESULTS: The time from onset to computed tomography scan slightly differed between groups (177 ± 160 min for control vs. 297 ± 305 min for the celecoxib group; P = 0.10). In the primary end-point analysis using cut-off values, there was a significant shift to reduced expansion of PHE in the celecoxib group (P = 0.005). With respect to the secondary end-points, there was also a significant shift to reduced expansion of ICH in the celecoxib group (P = 0.046). In addition, the expansion rate of PHE at follow-up tended to be higher in the control group than in the celecoxib group (90.6 ± 91.7% vs. 44.4 ± 64.9%; P = 0.058). CONCLUSIONS: In our small, pilot trial, administration of celecoxib in the acute stage of ICH was associated with a smaller expansion of PHE than that observed in controls.
28
Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality.
Joseph P. Broderick, Thomas G. Brott, John E. Duldner et al. · Stroke · 1993 · 1.7K citations
Medicine, Neurology, Neurosurgery +12
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
Lewis B. Morgenstern, J. Claude Hemphill, Craig S. Anderson et al. · Stroke · 2010 · 1.5K citations · Full text
Medicine, Neurology, Neurosurgery +12
Early Hemorrhage Growth in Patients With Intracerebral Hemorrhage
Thomas G. Brott, Joseph P. Broderick, Rashmi Kothari et al. · Stroke · 1997 · 1.5K citations